In one paragraphArticle in Virulence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Marek StefanDepartment of Infectious Diseases and Travel Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0009-0001-4823-6704 Marie BrajerovaDepartment of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0000-0002-5737-7859 Suhanya PrasadDepartment of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0000-0002-2832-6761 Eliska BebrovaDepartment of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0009-0003-2187-5105 Jan BerousekDepartment of Anaesthesiology and Intensive Care, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0000-0001-5405-1469 Jiri PozniakThird Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0000-0002-1886-7433 Silvia JarosciakovaThird Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Andrea RennerovaChildhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0000-0002-0510-1543 Tomas MilotaDepartment of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0000-0003-2105-3462 Otakar NycDepartment of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Pavel DrevinekDepartment of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0000-0002-8994-5240 Marcela KrutovaDepartment of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0000-0002-4511-9430 Milan TrojanekDepartment of Infectious Diseases and Travel Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.ORCID 0000-0003-1488-6546 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Since late 2022, an increase in
Indexed as
Streptococcal InfectionsStreptococcus pyogenesAdultAgedAnti-Bacterial AgentsBacteremiaFasciitis, NecrotizingFemaleHumansMaleMiddle AgedRecurrenceType IV Secretion SystemsVirulenceWhole Genome SequencingAnti-Bacterial AgentsType IV Secretion SystemsCD19+ deficiencycellulitislectin pathway complement deficiencynecrotizing fasciitissepsisStreptococcus pyogenes
Identifiers
PMID41017571
PMCPMC12482427
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390